Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study

被引：1

作者：

Hannawi, Suad ^{[1
]}

Zhang, Rong-Rong ^{[2
]}

Abuquta, Alaa ^{[3
]}

Safeldin, Linda ^{[4
]}

Hassan, Aala ^{[4
]}

Alamadi, Ahmad ^{[4
]}

Hossain, Tasmiah ^{[4
]}

Mostafa, Mohamed ^{[5
]}

Ghoneim, Yasser ^{[5
]}

Solo, Jennifer ^{[5
]}

Zheng, Hong-Xia ^{[6
]}

Wu, Ding-Feng ^{[6
]}

Yu, Dan-Dan ^{[6
]}

Yuan, Jia-Cheng ^{[6
]}

Zhao, Di ^{[6
]}

Lin, Rui ^{[6
]}

Ying, Bo ^{[6
,8
]}

Qin, Cheng-Feng ^{[2
,7
]}

机构：

[1] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Internal Med Dept, Emirates Hlth Serv EHS, Dubai, U Arab Emirates

[2] Acad Mil Med Sci AMMS, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China

[3] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Accid & Emergency Dept, EHS, Dubai, U Arab Emirates

[4] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Gen Surg Dept, EHS, Dubai, U Arab Emirates

[5] PDC FZ LLC, Contract Res Org, Dubai, U Arab Emirates

[6] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou, Peoples R China

[7] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China

[8] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou 215123, Peoples R China

来源：

CLINICAL AND TRANSLATIONAL MEDICINE | 2023年 / 13卷 / 08期

关键词：

D O I：

10.1002/ctm2.1387

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[1] Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Modjarrad, Kayvon
Roberts, Christine C.
Mills, Kristin T.
Castellano, Amy R.
Paolino, Kristopher
Muthumani, Kar
Reuschel, Emma L.
Robb, Merlin L.
Racine, Trina
Oh, Myoung-don
lamarre, Claude
Zaidi, Faraz I.
Boyer, Jean
Kudchodkar, Sagar B.
Jeong, Moonsup
Darden, Janice M.
Park, Young K.
Scott, Paul T.
Remigio, Celine
Parikh, Ajay P.
Wise, Megan C.
Patel, Ami
Duperret, Elizabeth K.
Kim, Kevin Y.
Choi, Hyeree
White, Scott
Bagarazzi, Mark
May, Jeanine M.
Kane, Deborah
Lee, Hyojin
Kobinger, Gary
Michael, Nelson L.
Weiner, David B.
Thomas, Stephen J.
Maslow, Joel N.
LANCET INFECTIOUS DISEASES, 2019, 19 (09): : 1013 - 1022
[2] Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults
Paradis, Erin M.
Tikhonov, Oleg
Cao, Xin
Kharit, Susanna M.
Fokin, Aleksandr
Platt, Heather L.
Banniettis, Natalie
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4177 - 4182
[3] Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile
Bueno, Susan M.
Abarca, Katia
Gonzalez, Pablo A.
Galvez, Nicolas M. S.
Soto, Jorge A.
Duarte, Luisa F.
Schultz, Barbara M.
Pacheco, Gaspar A.
Gonzalez, Liliana A.
Vazquez, Yaneisi
Rios, Mariana
Melo-Gonzalez, Felipe
Rivera-Perez, Daniela
Iturriaga, Carolina
Urzua, Marcela
Dominguez, Angelica
Andrade, Catalina A.
Berrios-Rojas, Roslye, V
Canedo-Marroquin, Gisela
Covian, Camila
Moreno-Tapia, Daniela
Saavedra, Farides
Vallejos, Omar P.
Donato, Paulina
Espinoza, Pilar
Fuentes, Daniela
Gonzalez, Marcela
Guzman, Paula
Munoz Venturelli, Paula
Perez, Carlos M.
Potin, Marcela
Rojas, Alvaro
Fasce, Rodrigo A.
Fernandez, Jorge
Mora, Judith
Ramirez, Eugenio
Gaete-Argel, Aracelly
Oyarzun-Arrau, Aaron
Valiente-Echeverria, Fernando
Soto-Rifo, Ricardo
Weiskopf, Daniela
Sette, Alessandro
Zeng, Gang
Meng, Weining
Gonzalez-Aramundiz, Jose, V
Kalergis, Alexis M.
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E792 - E804
[4] Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study
Tomita, Noriko
Morino, Eriko
Terada-Hirashima, Junko
Uemura, Yukari
Shimizu, Yosuke
Saito, Sho
Suzuki, Tetsuya
Okumura, Nobumasa
Iwasaki, Haruka
Ebihara, Hideki
Shimojima, Masayuki
Sugiura, Wataru
Ohmagari, Norio
Ujiie, Mugen
LIFE-BASEL, 2023, 13 (03):
[5] A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults
Marshall, Helen S.
Richmond, Peter C.
Nissen, Michael D.
Wouters, Ann
Baber, James
Jiang, Qin
Anderson, Annaliesa S.
Jones, Thomas R.
Harris, Shannon L.
Jansen, Kathrin U.
Perez, John L.
VACCINE, 2013, 31 (12) : 1569 - 1575
[6] A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults
Micha Loebermann
Carlos Fritzsche
Hilte Geerdes-Fenge
Esther Heijnen
Daniel Kirby
Emil C. Reisinger
Infection, 2019, 47 : 105 - 109
[7] A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (OptafluA®) in healthy adults
Loebermann, Micha
Fritzsche, Carlos
Geerdes-Fenge, Hilte
Heijnen, Esther
Kirby, Daniel
Reisinger, Emil C.
INFECTION, 2019, 47 (01) : 105 - 109
[8] Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial
Landier, Wendy
Bhatia, Smita
Wong, F. Lennie
York, Jocelyn M.
Flynn, Jessica S.
Henneberg, Harrison M.
Singh, Purnima
Adams, Kandice
Wasilewski-Masker, Karen
Cherven, Brooke
Jasty-Rao, Rama
Leonard, Marcia
Connelly, James A.
Armenian, Saro H.
Robison, Leslie L.
Giuliano, Anna R.
Hudson, Melissa M.
Klosky, James L.
LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (01): : 38 - 48
[9] Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents
Paradis, Erin M.
Tikhonov, Oleg
Cao, Xin
Kharit, Susanna M.
Fokin, Aleksandr
Platt, Heather L.
Wittke, Frederick
Jotterand, Veronika
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4183 - 4189
[10] Safety and immunogenicity from a Phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine
Lin, Jiang-Tao
Zhong, Jian-San
Su, Nan
Xu, Jion-Guo
Wang, Nan
Chen, Jiang-Ting
Chen, Xin
Liu, Yu-Xuan
Gao, Hong
Jia, Yu-Ping
Liu, Yan
Sun, Rui-Huo
Wang, Xu
Yu, Dong-Zheng
Hai, Rong
Gao, Qiang
Ning, Ye
Wang, Hong-Xig
Li, Ma-Chao
Kan, Biao
Dong, Guan-Mu
An, Qi
Wang, Ying-Qun
Han, Jun
Qin, Chuan
Yin, Wei-Dong
Dong, Xiao-Ping
ANTIVIRAL THERAPY, 2007, 12 (07) : 1107 - 1113

← 1 2 3 4 5 →